The Leukemia & Lymphoma Society and Institute for Follicular Lymphoma Innovation announced a new partnership on a $20-million initiative to fund research in follicular lymphoma, the most common slow-growing non-Hodgkin’s lymphoma.
[The Leukemia & Lymphoma Society (PR Newswire)]